Healthcare provider profile · identity verified

Michael Cabasug, MD

Family Practice · KENNEWICK, WA · NPI 1538351176

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	578	189
Lisinopril	Lisinopril	462	153
Losartan Potassium	Losartan Potassium	360	97
Amlodipine Besylate	Amlodipine Besylate	312	93
Metformin Hcl	Metformin Hcl	295	83
Levothyroxine Sodium	Levothyroxine Sodium	287	92
Metoprolol Succinate	Metoprolol Succinate	277	75
Omeprazole	Omeprazole	271	93
Simvastatin	Simvastatin	249	64
Hydrochlorothiazide	Hydrochlorothiazide	246	76
Gabapentin	Gabapentin	234	69
Albuterol Sulfate Hfa	Albuterol Sulfate	230	53
Tamsulosin Hcl	Tamsulosin Hcl	171	61
Furosemide	Furosemide	164	51
Trazodone Hcl	Trazodone Hcl	142	47
Rosuvastatin Calcium	Rosuvastatin Calcium	141	50
Zolpidem Tartrate	Zolpidem Tartrate	123	18
Montelukast Sodium	Montelukast Sodium	119	35
Potassium Chloride	Potassium Chloride	118	37
Alprazolam	Alprazolam	116	18
Metoprolol Tartrate	Metoprolol Tartrate	108	28
Sertraline Hcl	Sertraline Hcl	107	30
Famotidine	Famotidine	106	31
Bupropion Xl	Bupropion Hcl	105	31
Metformin Hcl Er	Metformin Hcl	105	33
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	103	23
Fluticasone Propionate	Fluticasone Propionate	97	38
Eliquis	Apixaban	88	24
Lovastatin	Lovastatin	87	24
Alendronate Sodium	Alendronate Sodium	84	24
Jardiance	Empagliflozin	81	24
Glipizide Er	Glipizide	75	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	75	22
Glipizide	Glipizide	70	16
Ibuprofen	Ibuprofen	70	24
Pravastatin Sodium	Pravastatin Sodium	68	21
Escitalopram Oxalate	Escitalopram Oxalate	67	19
Citalopram Hbr	Citalopram Hydrobromide	66	20
Venlafaxine Hcl Er	Venlafaxine Hcl	66	12
Pantoprazole Sodium	Pantoprazole Sodium	63	24
Meloxicam	Meloxicam	61	17
Ozempic	Semaglutide	60	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	17
Carvedilol	Carvedilol	58	19
Pioglitazone Hcl	Pioglitazone Hcl	58	17
Spironolactone	Spironolactone	57	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	17
Duloxetine Hcl	Duloxetine Hcl	55	20
Oxybutynin Chloride Er	Oxybutynin Chloride	54	13
Atenolol	Atenolol	53	13
Naproxen	Naproxen	53	19
Allopurinol	Allopurinol	51	18
Fluoxetine Hcl	Fluoxetine Hcl	50	14
Prednisone	Prednisone	50	13
Propranolol Hcl	Propranolol Hcl	50	15
Finasteride	Finasteride	49	12
Warfarin Sodium	Warfarin Sodium	48	suppressed
Clopidogrel	Clopidogrel Bisulfate	47	13
Pregabalin	Pregabalin	43	11
Baclofen	Baclofen	41	suppressed
Trulicity	Dulaglutide	41	suppressed
Celecoxib	Celecoxib	40	14
Ondansetron Odt	Ondansetron	40	11
Farxiga	Dapagliflozin Propanediol	39	suppressed
Tradjenta	Linagliptin	39	11
Amitriptyline Hcl	Amitriptyline Hcl	38	12
Diclofenac Sodium	Diclofenac Sodium	38	11
Buspirone Hcl	Buspirone Hcl	37	12
Tizanidine Hcl	Tizanidine Hcl	37	12
Lorazepam	Lorazepam	36	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	33	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	24
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Acyclovir	Acyclovir	32	16
Hydrocortisone	Hydrocortisone	32	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Symbicort	Budesonide/Formoterol Fumarate	32	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	11
Levetiracetam	Levetiracetam	29	suppressed
Myrbetriq	Mirabegron	29	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Lansoprazole	Lansoprazole	28	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	28	28
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	23	suppressed
Glimepiride	Glimepiride	22	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	21	12
Lamotrigine	Lamotrigine	21	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Prazosin Hcl	Prazosin Hcl	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Loperamide	Loperamide Hcl	18	suppressed
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Clotrimazole	Clotrimazole	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Estradiol	Estradiol	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Trospium Chloride Er	Trospium Chloride	16	suppressed
Vascepa	Icosapent Ethyl	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Nystatin	Nystatin	14	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	12	12
Carbamazepine	Carbamazepine	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Valsartan	Valsartan	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error